Expression of miR-155 in CD14+ PBM in RA patients is higher than in HC and miR155 is involved in overexpression of chemokines (CCL) CCL3, CCL4, CCL5, CCL8 and chemokine receptor (CCR) CCR2 and CCR7. Here, CCR2 is linked to rheumatoid arthritis.